首页 工具
登录
购物车

搜索结果

Search Results for " l0081 "

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T27245L Eflucimibe

L0081,F-12511

Acyltransferase Metabolism
Eflucimibe (L0081) 是一种酰基辅酶A:胆固醇酰基转移酶抑制剂,可用于治疗心血管疾病和内分泌与代谢疾病,可用于研究动脉粥样硬化和高脂血症。
T27245 (RS)-Eflucimibe

F12511,L-0081,F-12511,L0081

Eflucimibe is an ACAT inhibitor. Eflucimibe regulates endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet. In vivo, orally administered Eflucimibe displayed high potency and efficacy as an antihypercholesterolemic compound in different cholesterol-fed animals (guinea-pig, rat, rabbit).

化合物

Eflucimibe
Cat.No: T27245L
Synonym: L0081,F-12511
Target: Acyltransferase
(RS)-Eflucimibe
Cat.No: T27245
Synonym: F12511,L-0081,F-12511,L0081
Target:
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼